pet-ct

Documents about pet-ct

• Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors#889225ClinicalTrials.gov
• 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study#890707ClinicalTrials.gov
• Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma#902235ClinicalTrials.gov
• 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer#979084ClinicalTrials.gov
• Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions#993618ClinicalTrials.gov
• Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT#853213ClinicalTrials.gov
• Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapy#971235HAL (France)
• Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers#1030297ClinicalTrials.gov
• The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma#129236PMC Full-Text (OAI)
• Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohorts.#148284NCBI PubMed Central
• A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer#300264ClinicalTrials.gov
• Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation#312111HAL (France)
• THU0276 Comparison of Two Different Scoring Methods for the Evaluation of Articular and Vascular FDG-PET/CT Uptake in PMR Patients#315150IRIS
• The Role Of 18f-fdg Pet/CT In Comparison With Computed Tomography In The Restaging Of Breast Cancer In Malaysia#397668USM Repository
• Detection without calibration: benchmarking domestic and international large language models for quality control of Mandarin 18F-FDG PET/CT reports#401686bioRxiv / medRxiv
• Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer#832354ClinicalTrials.gov
• Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms#842095ClinicalTrials.gov
• Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer#845798ClinicalTrials.gov
• Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer#854567ClinicalTrials.gov
• Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)#887494ClinicalTrials.gov
• PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer#893881ClinicalTrials.gov
• Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic Scans#917457ClinicalTrials.gov
• Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection#805150ClinicalTrials.gov
• 18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital#669999HAL (France)
• [^18F]FDG PET/CT value in the diagnostic evaluation of patients with polyarteritis nodosa#219872Springer Nature OA
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC#234423ClinicalTrials.gov
• (F-18)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy#260053Infoscience
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer#366603ClinicalTrials.gov
• Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer#405215ClinicalTrials.gov
• Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer#444872ClinicalTrials.gov
• Optimizing acquisition time and injected dose in (18)F-FDG PET/CT imaging using deep learning: enhancing image protocol efficiency and safety.#446160NCBI PubMed Central
• Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients#454034ClinicalTrials.gov
• Diagnostic performance of (18)F-FDG PET/CT in the prediction of axillary lymph node metastasis in Luminal A breast cancer.#625924NCBI PubMed Central
• Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?#665120HAL (France)
• Prediction of histological response by PET-CT after 2 weeks of neoadjuvant chemo-radiotherapy for rectal cancer: a prospective clinical trial.#666079NCBI PubMed Central
• BS: Take the Hint - Interactive Multitracer PET/CT Lesion Segmentation with a Scribble-Conditioned ResEnc U-Net#821583arXiv (All)
• The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)#827262ClinicalTrials.gov
• PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404#827359ClinicalTrials.gov
• Knowledge and Attitudes About Advanced Maxillofacial Imaging in Dental Professionals#829993ClinicalTrials.gov
• Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)#868321ClinicalTrials.gov
• Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer#872297ClinicalTrials.gov
• Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer#878663ClinicalTrials.gov
• A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms#890376ClinicalTrials.gov
• A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma#894378ClinicalTrials.gov
• 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients#916213ClinicalTrials.gov
• MetaStructAtlas: A Grounded 3D Vision-Language Dataset and Benchmark for Functional and Structural Reasoning in Whole-Body PET/CT#926584arXiv (All)
• The Role of 68Ga-FAPI-04 PET/CT as a Problem Solving Imaging Modality in Various Malignancies#1031284ClinicalTrials.gov
• Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617#1031473ClinicalTrials.gov
• A Head-to-Head Comparison Between [18F]Fluorodeoxyglucose ([18F]FDG) Positron Emission Tomography/Computed Tomography (PET/CT) and 99m Technetium-Hexamethylpropilene Amine Oxime (HMPAO)-Labeled Leuhocyte Scintingraphy in a Case Series of Patients with Suspected Vascular Prosthesis Infection: To Trust Is Good, but to Check Is Better#430418IRIS
• Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG#1030933ClinicalTrials.gov